UBS, a Swiss multinational investment bank, has appointed Ronald Jansen as Managing Director as the Head of Data & Analytics for Corporate Client Solutions this month. Jansen joins the Swiss Bank from Goldman Sachs, where he worked for 13 years.
In his new role, Jansen will head the firm’s data lab. During his tenure at Goldman Sachs, Jansen led a global team within the investment bank. According to his LinkedIn profile, Jansen’s team focused on M&A, capital markets, and derivatives structuring. In 2010, Jansen was promoted to Managing Director.
Before his time at Goldman Sachs, Jansen looked like he was set on a rather different career path. Between 1995 to 1996 he studied at Dartmouth College, where he earned a Bachelor of Engineering – BE. At the same time, from 1992 to 1997, Jansen was studying a Master of Engineering in the field of Chemical and Mechanical Engineering at RWTH Aachen University. The university is a leading European institution for science and research.
B2Broker Extends its Multi-Asset Liquidity Pool with New IntegrationsGo to article >>
Following this, Jansen attended Yale University where he graduated with a Ph.D. in Bioinformatics in 2002. After his graduation, he went on to do a research fellow for two years at Computational Biology Center, Memorial Sloan-Kettering. During this time, Jansen focused on bioinformatics combined with systems biology to study signal processing in cells. These were based on mathematical models and computational simulations.
UBS is investing in alternative research
The appointment of Jansen, with his experience in Science and research, comes as no surprise. This is because the investment bank has recently made a large investment in alternative research, according to a report from Business Insider.
In July this year, the investment bank also reported solid second-quarter earnings for 2018. The investment bank was a stand out for the group. Pre-tax profits again surprised on the upside, coming in at CHF 569 million. This is up 21 percent from the same period last year, which reported a figure of CHF 451 million.